Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 St. Jude Medical Issues Lead Wire Advisory Letter - Medical Product Outsourcing

St. Jude Medical Issues Lead Wire Advisory Letter

Though not a recall, the letter warns physicians to be vigilant in their monitoring of affected implanted cardio devices.

St. Jude Medical is voluntarily telling doctors about a potential problem with its left ventricular lead wires. According to the company, its QuickSite and QuickFlex LV lead wires used to connect cardiac resynchronization therapy (CRT) devices to the heart occasionally have become exposed on their silicone ends. St. Jude only has confirmed 39 cases of exposure out of 171,000 leads sold globally thus far, which works out to 0.023 percent.

The risk posed by exposed leads is that they may cause an electrical short in the implanted CRT device—there have, however, been no reports of adverse effects or injury caused by lead exposure. St. Jude’s letter to physicians merely is a conservative measure intended to inform medical practitioners of possible risks associated with the leads. The St. Paul, Minn.-based company recommends that physicians “continue to monitor their patient’s implanted system at regularly scheduled intervals with attention paid to diagnostic information related to LV pacing performance.”

This communication comes after Heart Rhythm Journal published a study in March examining the St. Jude recall of its Riata and Riata ST leads last year. Those leads were the direct cause of 22 deaths, according to the Journal, though St. Jude maintains that the number actually is 20.

St. Jude’s QuickFlex µ and Quartet Optim leads are not included in this advisory. These leads are insulated with the specially patented material Optim, while the Quicksite and QuickFlex LV leads are coated with conventional silicone.

St. Jude’s products are targeted to the cardiac rhythm management, atrial fibrillation, cardiovascular and neuromodulation markets.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters